Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Recombinant DNA Technology Market to reach USD XX billion by the end of 2030.

Global Recombinant DNA Technology Market Size Study & Forecast, by Product (Medical, Non-medical), By Component Type (Expression System, Cloning Vector), By Application (Food & Agriculture, Health & Disease, Environment, Others), By End-use (Pharmaceutical & Biotech Companies, Academic & Research Institutes, and Other), And Regional Analysis, 2023-2030

Product Code: HLSB-48447753
Publish Date: 27-06-2023
Page: 200

Global Recombinant DNA Technology Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Recombinant DNA Technology is a method primarily used to alter the phenotype of an organism (host) after introducing and integrating a genetically changed vector into the organism’s genome. This procedure essentially entails the introduction of an unfamiliar piece of DNA structure into the genome that houses our gene of interest. Recombinant DNA technology is used to create newly developed recombinant genes. Recombinant DNA technology uses several techniques, equipment, and other particular procedures to produce artificial DNA in order to create the desired result. The rising government initiatives, rising emergence of recombinant insulin, surging demand for recombinant/ genetically modified products, coupled with the rising prevalence of chronic diseases are the most prominent factors that are propelling the market demand across the globe.

Additionally, the rapid expansion of the biopharmaceutical industry is playing a significant role in augmenting the global market expansion. Biopharmaceuticals are drugs that are produced using living organisms, and many of them are developed using recombinant DNA technology. According to Statista, in 2022, the biopharmaceuticals sector was estimated to account for USD 403.1 billion across the globe, which is projected to constantly rise and estimated to reach USD 974.5 billion by 2030. Also, the continuous progress of rDNA techniques has created novel opportunities for biopharmaceutical research by enabling the formation of a recombinant DNA molecule. The adoption of this technology is anticipated to be fueled by the presence of a strong biopharmaceuticals pipeline, particularly the pipeline for recombinant proteins. The expansion of this market is largely attributable to the development of recombinant products using rDNA techniques in conjunction with CRISPR/Cas9 nuclease, ZFN, and TALEN enabling simple & accurate genome editing with no constraints by organisms. Numerous review studies conducted by researchers have demonstrated the effectiveness of rDNA technology. Moreover, the technological advancements in genomics, as well as the rising R&D initiatives and strategic collaborations by market players presents various lucrative opportunities over the forecasting years. However, the risks associated with the use of genetically modified food and regulatory, scientific, and ethical challenges related with gene therapy are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Recombinant DNA Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of biopharmaceutical manufacturing companies, along with growing research and development activities. For instance, in May 2022, PharmaJet announced that the National Institute on Ageing (NIA) branch of the National Institutes of Health (NIH) granted its partner, the Institute for Molecular Medicine (IMM), a USD 12 million award. The award funds the development of beta-amyloid vaccines based on recombinant proteins and DNA for the treatment and prevention of Alzheimer’s disease (AD). Such studies are accelerating the market’s expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The presence of low-cost manufacturing centers, rising awareness regarding the benefits of this technology, increasing patient pool, as well as rising investments by many government organizations are significantly propelling the market demand across the region.

Major market players included in this report are:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Amgen Inc
Novartis AG
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Merck & Co., Inc.

Recent Developments in the Market:
Ø In March 2022, VBI Vaccines Inc. unveiled the launch of PreHevbrio (Recombinant Hepatitis B Vaccine) for the treatment of individuals 18 years of age and older patients are at risk of contracting any of the identified subtypes of the hepatitis B virus (HBV).
Ø In February 2022, the 3-antigen hepatitis B (HBV) vaccine manufactured by VBI Vaccines Inc. under the trade name PreHevbri received approval from the European Medicines Agency’s Committee for Medicinal Products for Human Use. This vaccine is intended to protect adults from an infection caused by a particular subtype of the hepatitis B virus.

Global Recombinant DNA Technology Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Component Type, Application, End-use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

By Component Type:
Expression System
Cloning Vector

By Application:
Food & Agriculture
Health & Disease

By End-use:
Pharmaceutical & Biotech Companies
Academic & Research Institutes

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Recombinant DNA Technology Market, by Region, 2020-2030 (USD Billion)
1.2.2. Recombinant DNA Technology Market, by Product, 2020-2030 (USD Billion)
1.2.3. Recombinant DNA Technology Market, by Component Type, 2020-2030 (USD Billion)
1.2.4. Recombinant DNA Technology Market, by Application, 2020-2030 (USD Billion)
1.2.5. Recombinant DNA Technology Market, by End-use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Recombinant DNA Technology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Recombinant DNA Technology Market Dynamics
3.1. Recombinant DNA Technology Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rapid expansion of the biopharmaceutical industry Surging demand for recombinant/ genetically modified products
3.1.2. Market Challenges Risks associated with the use of genetically modified food Regulatory, scientific, and ethical challenges related with gene therapy
3.1.3. Market Opportunities Technological advancements in genomics Rising R&D initiatives and strategic collaborations by market players
Chapter 4. Global Recombinant DNA Technology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Recombinant DNA Technology Market, by Product
5.1. Market Snapshot
5.2. Global Recombinant DNA Technology Market by Product, Performance – Potential Analysis
5.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Recombinant DNA Technology Market, Sub Segment Analysis
5.4.1. Medical
5.4.2. Non-medical
Chapter 6. Global Recombinant DNA Technology Market, by Component Type
6.1. Market Snapshot
6.2. Global Recombinant DNA Technology Market by Component Type, Performance – Potential Analysis
6.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Component Type 2020-2030 (USD Billion)
6.4. Recombinant DNA Technology Market, Sub Segment Analysis
6.4.1. Expression System
6.4.2. Cloning Vector
Chapter 7. Global Recombinant DNA Technology Market, by Application
7.1. Market Snapshot
7.2. Global Recombinant DNA Technology Market by Application, Performance – Potential Analysis
7.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Recombinant DNA Technology Market, Sub Segment Analysis
7.4.1. Food & Agriculture
7.4.2. Health & Disease
7.4.3. Environment
7.4.4. Others
Chapter 8. Recombinant DNA Technology Market, by End-use
8.1. Market Snapshot
8.2. Global Recombinant DNA Technology Market by End-use, Performance – Potential Analysis
8.3. Global Recombinant DNA Technology Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
8.4. Recombinant DNA Technology Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biotech Companies
8.4.2. Academic & Research Institutes
8.4.3. Others
Chapter 9. Global Recombinant DNA Technology Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Recombinant DNA Technology Market, Regional Market Snapshot
9.4. North America Recombinant DNA Technology Market
9.4.1. U.S. Recombinant DNA Technology Market Product breakdown estimates & forecasts, 2020-2030 Component Type breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030 End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Recombinant DNA Technology Market
9.5. Europe Recombinant DNA Technology Market Snapshot
9.5.1. U.K. Recombinant DNA Technology Market
9.5.2. Germany Recombinant DNA Technology Market
9.5.3. France Recombinant DNA Technology Market
9.5.4. Spain Recombinant DNA Technology Market
9.5.5. Italy Recombinant DNA Technology Market
9.5.6. Rest of Europe Recombinant DNA Technology Market
9.6. Asia-Pacific Recombinant DNA Technology Market Snapshot
9.6.1. China Recombinant DNA Technology Market
9.6.2. India Recombinant DNA Technology Market
9.6.3. Japan Recombinant DNA Technology Market
9.6.4. Australia Recombinant DNA Technology Market
9.6.5. South Korea Recombinant DNA Technology Market
9.6.6. Rest of Asia Pacific Recombinant DNA Technology Market
9.7. Latin America Recombinant DNA Technology Market Snapshot
9.7.1. Brazil Recombinant DNA Technology Market
9.7.2. Mexico Recombinant DNA Technology Market
9.8. Middle East & Africa Recombinant DNA Technology Market
9.8.1. Saudi Arabia Recombinant DNA Technology Market
9.8.2. South Africa Recombinant DNA Technology Market
9.8.3. Rest of Middle East & Africa Recombinant DNA Technology Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. F. Hoffmann-La Roche Ltd (Genentech, Inc) Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.3.2. Profacgen
10.3.3. Amgen Inc
10.3.4. Novartis AG
10.3.5. GenScript
10.3.6. Pfizer Inc
10.3.7. Novo Nordisk A/S
10.3.8. Eli Lilly and Company
10.3.9. Sanofi
10.3.10. Merck & Co., Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now